Search Results for "Addenbrooke Cognitive Examination Scoring"
Original Source: Adaptation of Addenbrooke's Cognitive Examination-Revised for the Greek population.
Background/Purpose: Addenbrooke's Cognitive Examination-Revised [1] is a highly sensitive and specific bedside test for the diagnosis of dementia. The aim of this study was to validate a Greek version of this simple, bedside instrument and to investigate its psychometric properties. Method: We translated and administered the Greek version of the ACE-R to 95 individuals comprising two groups: a dementia group (n = 35) and an age-matched and education-matched healthy control group (n = 60). Results: Our resul...
Matching Channels
Cognitive Bias Modification (CBM)
Cognitive Bias Modification (CBM) is new psychiatric therapy; involving just a few 15-minute sessions and no drugs, discussion of feelings, or even a psychiatrist, it is described as a cognitive vac...
Dementia describes a range of symptoms of cognitive decline. For example memory loss, problems with reasoning and communication skills, and a reduction in a person's abilities and skills in carr...
Noonan Syndrome and related disorders (rasopathies) are autosomal dominant congenital syndromes. These disorders are characterised by facial dysmorphism, a wide spectrum of cardiac disease, postnata...
Matching News
Addenbrooke's nurse wins national award
A nurse from Addenbrooke’s Hospital in Cambridgeshire has been given a national NHS award for his mentoring and teaching skills.
MRI-based semiquantitative scoring of joint pathology in osteoarthritis
Semiquantitative MRI-based scoring of joint pathology is a powerful tool in osteoarthritis (OA) research, which provides valuable information on the natural history of the disease and can be used in o...
FDA Takes Its Tablet-Scoring Guidance To An Advisory Committee
On Aug. 9, FDA’s Pharmaceutical Science and Clinical Pharmacology panel will discuss the agency’s year-old draft guidelines on the data needed to support functional scoring of tablets. Issues rela...
Coronary Angiographic Scoring Systems
Are scoring systems valid estimators of CAD plaque burden? American Heart Journal
Table: Scoring comparative benefit
Rating innovation Scoring comparative benefit Germany's Institute for Quality and Efficiency in Health Care (IQWiG) and Federal Joint Committee (G-BA) use a six-point rating scale to classify the adde...
FDA’s Tablet ‘Scoring’ Guidance Aims to Bridge Generic, Brand Divide
Marketed drugs will not need to be tested under final guidelines on 'tablet scoring' for branded and generic medicines issued by the US Food and Drug Administration (FDA) this week.
Tablet Scoring Guidance Could Drop Patient Testing Recommendation
FDA’s Advisory Committee for Pharmaceutical Science and Clinical Pharmacology unanimously rejects an idea to test tablet scoring in the relevant patient population, saying there is too much potentia...
FDA’s Top-Four Tablet Scoring Concerns To Get Advisory Committee Review
The Advisory Committee for Pharmaceutical Science and Clinical Pharmacology will vote on some aspects of FDA’s draft scoring guidance, potentially giving generic industry a clue of future agency act...
Matching PubMed Articles
There is a clear need for brief, but sensitive and specific, cognitive screening instruments for dementia. We assessed the diagnostic accuracy of the Japanese version of Addenbrooke's Cognitive Examin...
Introduction: The motor features of corticobasal syndrome (CBS) are well recognized but the fact that many, if not all, affected patients develop cognitive impairment is still underrecognized. The dem...
OBJECTIVE: To evaluate how much the Addenbrooke's Cognitive Examination-revised (ACE-R) improves the estimate of cognitive ability from the Mini-Mental State Examination (MMSE) in people with Alzheime...
We report a pilot investigation into the utility of screening tools in Mild Cognitive Impairment (MCI). The Addenbrooke's Cognitive Examination-Revised (ACE-R), Montreal Cognitive Assessment (MoCA) an...
Adaptation of Addenbrooke's Cognitive Examination-Revised for the Greek population.
Background/Purpose: Addenbrooke's Cognitive Examination-Revised [1] is a highly sensitive and specific bedside test for the diagnosis of dementia. The aim of this study was to validate a Greek version...
